Introduction
AF4 (ALL-1 Fused to Four (Nakamura et al., 1993) , also called FEL (Morrissey et al., 1993) , is the 4q21 gene involved in the human acute lymphoblastic leukemia (ALL) associated t(4;11) (q21;q23) (Gu et al., 1992; Domer et al., 1993) . This translocation results in the fusion of AF4 with the 11q23 gene MLL (Zieman Van der Poel et al., 1991; Tkachuck et al., 1992) . MLL is involved in over 20 acute leukemia associated interchromosomal translocations (Bernard and Berger, 1995) of which the t(4;11) is the most common (Mitelman and Heim, 1992) . The vast majority of leukemias showing the t(4;11) translocation have an ALL phenotype (Mitelman and Heim, 1992) . However, the transformed cell in t(4;11) ALL appears to be distinct from that of common ALL because it shows features of both B-cell and myelomonocytic dierentiation. Patients with t(4;11) ALL have aggressive disease and a bleak prognosis (Pui et al., 1991) . We have chosen to study AF4 as a prototype MLL fusion partner.
All of the MLL translocations characterized at a molecular level have generated genes encoding in frame fusion mRNA's capable of producing novel chimeric proteins (Bernard and Berger, 1995) . Because of the lack of obvious similarity between most MLL fusion partners and the discovery of an internal MLL duplications in some myeloid leukemias (Schichman et al., 1994) some investigators have suggested leukemogenesis is the result of the creation of a dominant negative MLL (Fidanza et al., 1996) . In this model the fusion partner only contributes a protein stabilization domain. However, there is a strong correlation between the speci®c MLL/11q23 translocation and leukemia phenotype (Mitelman and Heim, 1992) and all characterized fusions maintain the open reading frame well into the fusion partner suggesting that sequences from the fusion partner may at least modulate the leukemia phenotype. The importance of the fusion partner in leukemogenesis is further supported by a murine model of the t(9;11)/MLL-AF9 fusion where a Mll-AF9 knock-in is leukemogenic while a truncated Mll is not (Corral et al., 1996) . Nakamura et al. (1993) and Morrissey et al. (1993) have cloned and sequenced the complete human AF4 cDNA's. The derived amino acid sequence of human AF4 reveals the protein to be serine and proline rich, contain putative nuclear targeting motifs and areas of concentrated basic charge. These features suggest that AF4 is a transcription factor. This has been supported by the identi®cation of a transcriptional activation domain in human AF4 (Prasad et al., 1995; Ma and Staudt, 1996) and the human AF4 homolog, LAF-4 (Ma and Staudt, 1996) . In other studies the LAF-4 gene product has been localized to the nucleus (Ma and Staudt, 1996) . A second AF4 homolog, FMR2, the putative Fragile X E (FRAXE) gene has also been isolated (Chakrabarti et al., 1996; Gecz et al., 1996; Gu et al., 1996) but its biochemical function has not yet been characterized.
Here we report the cloning of the murine homolog of the AF4 gene (Af4) and map its position in the mouse genome. We demonstrate the murine AF4 protein (mAF4) has transcriptional transactivation activity and have localized the mAF4 to the nucleus supporting the theory that AF4 is a transcription factor. We have undertaken an in situ hybridization analysis of Af4 expression in the adult and developing mouse which suggests an important role for Af4 expression in the development of the hematopoietic, cardiovascular, skeletal and central nervous system.
Results

Cloning of the Murine Homologue of AF4
A human cDNA clone pc664 was noted to cross hybridize with murine genomic DNA (not shown) and was used to isolate a cDNA from a murine pre-B cell cDNA library. This clone, pZ5b, contains 1210 base pairs of 3' open reading frame which was noted to be highly homologous to the derived amino acid sequence of human AF4. The mouse chromosomal location of pZ5b was determined by interspeci®c backcross analysis using progeny derived from matings of [(C57BLJ6J6Mus spretus)F16C57BL/6J] mice . C57BL/6J and M. spretus DNAs were digested with several enzymes and analysed by Southern blot hybridization for informative restriction fragment length polymorphisms (RFLPs) using the mouse cDNA probe. The mapping results indicated that the gene encoding pZ5b is located in the central region of mouse chromosome 5 linked to Albl, Fgf5 and Adrbk2 in the region syntenic to the human 4q21 region. The most likely gene order is: centromere-Albl ± Fgf5 ± AF4 ± Adrbk2 (Figure 1 ). In addition, no recombinants were detected between the locus identi®ed using the mouse cDNA probe and the locus identi®ed using the human AF4 probe, pc664, in 180 animals typed in common. This indicates that the two loci are within 1.7 cM of each other (upper 95% con®dence limit) (data not shown). Thus, the mapping data strongly support the notion that this clone is the authentic homolog of human AF4.
A second murine cDNA was isolated with pZ5b from a new born mouse kidney cDNA library. DNA sequence analysis of the two murine cDNA's identi®ed a 3633 base pair open reading frame (Figure 2a ). BESTFIT alignment (Wisconsin Package, Version. 2, 1994) of the derived amino acid sequence with the human AF4 amino acid sequence suggests the ®rst six amino acids are missing from the murine open reading frame (Figure 2a ). Over the regions used in this alignment the human and mouse derived amino acid sequences are 74.4% identical and 84.4% conservative of amino acid type. Because of this high level of homology between the human and mouse derived amino acid sequences and the syntenic localization of the murine gene we conclude these clones represent the mouse homolog of AF4.
As was noted in the human derived amino acid sequence murine AF4 protein (mAF4) is serine (16%) and proline (12%) rich. Data base homology searches using the FASTA (Wisconsin Package Version. 2, 1994) and BLAST (Altschul et al., 1990) programs revealed only small, weak homologies with proteins other than the known AF4 homologs. In a region of especially concentrated basic charge (starting at amino acid 809) there is a sequence similar to the DNA binding motifs of JunB and JunD (Figure 2b ) (Busch and Sassone-Corsi, 1990 ). There is a series of four leucine residues spaced with a seven amino acid periodicity from amino acid 176 ± 197. However unlike a leucine zipper motif the derived amino acid sequence in this region is not favorable for the formation of an alpha helix (Busch and Sassone-Corsi, 1990; Wisconsin Package, Version. 2, 1994) . Two regions of sequence homology with the nuclear targeting motif are present at amino acids 812 ± 816 and 885 ± 889 (La Casse and Lefebvre, 1995) .The most proline-rich region of the mouse AF4 protein is from amino acids 641 ± 685 where prolines account for 31% of the derived amino acid sequence.
In a similar BESTFIT analysis the overall mAF4 derived amino acid sequence is 36% identical to that of the human AF4 homolog LAF-4. An additional 16% of the amino acids show conservative changes. This is comparable to the overall 37% identity and 52% similarity between the human LAF-4 and human AF4 derived amino acid sequences. The putative Fragile X E gene, FMR2, shows 47% similarity at the level of derived amino acid sequence (Gu et al., 1996 ) to mAF4's derived amino acid sequence.
The mAF4 derived amino acid sequence was further aligned and compared to the human AF4, LAF-4 and (Figure 2a ). In this alignment there are three regions of strong conservation between the transactivation domains of the homologs and murine AF4; the motif MLEDDL (K/Q)LS (mAF4 amino acids 420 ± 428), the serine-rich motif (mAF4 amino acids 452-470), and the motif NKWQLD (K/N)WL (mAF4 amino acids 492 ± 500). In the putative JunB homology the amino acids are well conserved among AF4 homologs in the ®rst cluster of basic residues and the polarity of the amino acids in each position is well conserved in the more carboxy cluster of basic charge (Figure 2a ).
Murine AF4 has transcriptional transactivation activity
An EcoRI fragment encoding amino acids 1 ± 1173 (clone EcoRI) of the murine open reading frame in Figure 2a was cloned into the GAL-4 binding domain fusion vector pAS2-1 and assayed for transactivation in yeast (Vojtek et al., 1993) . This clone transactivated LacZ expression (not shown). The open reading frame was then subcloned by generating PCR products encoding the regions corresponding to sequence 5' of the breakpoint in the t(4;11), EcoRI-1, the region homologous to the transactivation domain in human AF4 (EcoRI-2), and two additional 3' regions (clones EcoRI-3 and Sal, see Figure 2a ). This analysis demonstrated a region of strong transactivation in the region homologous to the human transactivation domain but also demonstrated transactivation activity in the most 5' region of AF4 encoded by the EcoRI-1 clone (not shown).
This transactivation function was then analysed in mammalian cells with GAL4 DNA binding domain fusions. Using a reporter promoter construct with only GAL4 binding sites and a TATAA box the complete EcoRI and EcoRI-2 constructs activated transcription (Baron et al., 1997) in HeLa cells (Figure 3a) . Although the complete EcoRI construct only transactivated only slightly above the background, the EcoRI-2 clone activated transcriptions about 18-fold. No activation were observed with EcoRI-1 and EcoRI-3 using this minimal promoter reporter.
To analyse mAF4 transactivation with a more complex promoter a GAL4-HSVtk promoter containing CAT reporter plasmid (GAL4 5 -tkCAT) was used. In this reporter construct the GAL4 DNA binding sites are cloned upstream of two SP1 sites and a CAAT box from the Herpes Simplex Virus thymidine kinase promoter (Shi et al., 1991) . Using this reporter the EcoRI-1 clone showed transactivation activity in HeLa cells (11-fold) comparable to that of the EcoRI-2 clone (16-fold) ( Figure 3b ). Western blot analysis of transfected HeLa cell extract using a monoclonal anti-GAL4 DNA binding domain antibody revealed the AF4 subclones produced similar levels of protein (not shown).
Subcellular localization of the AF4 protein
A 3521 base pair fragment of mAF4 containing all but the terminal 38 amino acids of the open reading frame was fused in frame downstream of a Green Fluorescent Protein tag (GFP) (Chal®e et al., 1994) .
This protein was transiently expressed by transfection into the human cell lines HL-60 (acute myeloid leukemia) (Collins, 1987) , HeLa (cervical carcinoma) (Spence et al., 1988) and U2-OS (osteosarcoma) (Stea et al., 1988) . After 24 and 48 h the intracellular localization of green¯uorescence was determined (Figure 4) . In all three cell lines the green fluorescent signal was nuclear. In HeLa cells this nuclear uorescence was coarsely reticulated while in U2-OS cells the¯uorescence was more diuse. HL-60 cells gave a peripheral nuclear and nucleolar green uorescent pattern. Control transfection with antisense AF4 fused to GFP gave only weak, diuse, whole cell green¯uorescence in all three lines.
Adult expression of Af4
To assess the expression pattern of mAF4 in the adult mouse an Af4 cDNA was used to hybridize to a multitissue Northern blot ( Figure 5 ). This revealed a major transcription of 9.8 kb. There is a high level of expression in the kidney and moderate expression in brain, lung and liver with lower levels present in spleen, skeletal muscle, and testis. (However, spleen and testis are somewhat underloaded.) Expression of a 4.6 kb transcript is also detected on longer exposure in these tissues as well as unique transcripts in kidney and skeletal muscle (not shown).
To further examine these ®ndings in situ hybridization was performed on adult CD-1 mouse tissue using riboprobes transcribed from clones of a 303 base pair region near the 3' end of the Af4 open reading frame (nucleotides 3202 ± 3504). The riboprobes were labeled with digoxigenin and visualized using an anti-digoxigenin immunoperoxidase technique (Sasaki and Hogan, 1993; Sitzman et al., 1995) . This region of the cDNA lacks DNA sequence homology to human AF4, LAF-4 or FMR2. In all studies parallel antisense and sense (control) riboprobes were hybridized to serial sections and the control riboprobes failed to hybridized to any section.
Cardiac muscle does not express Af4 however endothelia lining the cardiac chambers and small vessels express the gene. The spleen (Figure 6 ) used in these studies is rich in extramedullary hematopoiesis and therefore it oers an opportunity to examine the full range of hematolymphoid development. This extramedullary hematopoiesis occurs in the red pulp where there is intense expression of Af4 in the myeloid, erthyroid and megakaryocytic lineages. In the white pulp, where the mature lymphocytes reside, expression of Af4 is less intense and more heterogeneous. There is strong expression in mantle zone B-cells but marked down-regulation in the more mature marginal zone Bcells (Figure 6b ). Expression is heterogenous in T-cell region with the exception of lymphocytes adjacent to vessels where there is uniform strong expression of Af4 (Figure 6b ). The germinal centers show heterogeneous Af4 expression with some germinal center blastic lymphocytes and the follicular dendritic cells intensely positive (not shown). Af4 expression in the adult hepatocytes is strong as with the sinusoid endothelia demonstrating a weaker signal. Despite the strong signal on Northern blot only the renal medullary tubule epithelia and cortical arteries express Af4. The bulk of renal cells, including the endothelial cells of the glomeruli, do not show hybridization. In the pancreas the acinar cells express Af4 but the islets and ducts do not. Although Af4 is expressed in mature gastrointestinal smooth muscle and lymphocytes in the lamina propria it is not expressed in the gastrointestinal epithelia (not shown).
a
Developmental expression pattern of Af4
The developmental expression pattern of Af4 was examined by in situ hybridization using serial sagittal and parasagittal sections of embryonic post coitus day 7.5 to 15.5 and 17.5 (E7.5 ± E15.5 and E17.5) CD-1 mouse embryos. At all stages parallel antisense and sense (control) riboprobes were hybridized to serial sections and the control riboprobe did not produce a signal in any sections.
In the E7.5 sections there is low level Af4 expression in the neuroplate ectoderm and ectoplacental cone. Expression is strong in the mesoderm, embryonic visceral endoderm and parietal endoderm. However, the extra-embryonic visceral endoderm does not express Af4 (Figure 7 ). In addition, invading trophoblasts are positive for Af4 hybridization. In the E8.5 embryo Af4 expression is more generalized in the embryo and at a higher level in both the embryo and invading trophoblasts (Figure 8a and b) . Some, but not all, hematopoietic cells and all endothelial cells of the blood islands express Af4 (Figure 8c and d) .
Expression throughout the embryo, extra embryonic membranes, and invading trophoblastic cells continues in the E9 ± 9.5 sections. Included among these Af4 expressing cells are those of the para-arotic splanchnopleura (not shown) which contains intra-embryonic hematopoietic precursors (Zion, 1995) . By E10.5 the beginning of Af4 down-regulation is observed. The sclerotomic condensations which will lead to the development of the vertebral bodies are negative on E10.5. The cardiomyocytes (Figure 9a and b) and endothelia of the heart, aorta, and umbilical veins have high levels of Af4. The sclerotomic condensations which will lead to the development of the vertebral bodies become positive for Af4 hybridization by E11.5 (not shown) but there is marked down-regulation of Af4 expression in the heart (Figure 9c and d) . There continues to be widespread expression in the central nervous system and Rathke's pouch. The developing eye expresses Af4 in the cells of the retinal anlagen as do the epithelia and smooth muscle precursors gastrointestinal system. The bronchiolar and Wolan duct epithelia and the hind limb bud show abundant Af4 RNA. This pattern of expression is maintained on E12.5.
The E13.5 sections show clearcut cartilaginous dierentiation and high levels of Af4 in the perichondral cells and chondrocytes of the primordial vertebral bodies. Af4 expression continues throughout the central nervous system and the neurons of the dorsal root ganglia. The gastrointestinal tract epithelia, lamina propria and smooth muscle and bronchiolar epithelia maintain high levels of expression. There is also weaker expression in the pulmonary parenchyma and pancreatic precursors. In the liver both the hepatocytes and hematopoietic tissue express AF4. The cells of the single layer skin show Af4 hybridization. The E14.5 sections show down-regulation of Af4 expression gastrointestinal tract epithelium but the expression is maintained in the smooth muscle of the gastrointestinal tract. There is also down-regulation in the bronchiolar epithelium but continuing expression in the parenchyma of the lung. There is still prominent Af4 expression in aortic endothelia (Figure 10a and b) and skeletal muscle. The skin has become layered and there is Af4 expression throughout its thickness. The skeletal muscle also expresses Af4. The E15.5 sections show the same pattern of Af4 expression with well de®ned expression in the basal cells of the hair follicles. In the vertebral bodies the expression of Af4 is more prominent in the perichondral cells with marked downregulation in the chondrocytes (Figure 10c and d) . The E17.5 sections show the central nervous system glia and neurones and the pituitary express Af4 (Figure  10e and f). The majority of the hepatic hematopoietic cells are strongly positive. However, the lineage of the Af4 positive cells cannot be determined. The hepatocytes are weakly positive and the cardiomyocytes continue to be negative. The skin's basal layer (not shown) is positive but more dierentiated layers have down-regulated Af4. There is a strong expression in skeletal muscle but ®broblasts are negative. The perichondral cells of the vertebral bodies maintain high levels of expression and chondrocytes elsewhere at earlier stages of ossi®cation have become strongly positive. Within the gastrointestinal tract only the smooth muscle and some lymphocytes show expression. The pulmonary alveolar cells weakly express Af4 but the epithelia of the airways and the pulmonary endothelia do not.
Discussion
Af4 is of interest because it is the most common MLL translocation fusion partner (Bernard and Berger, 1995) . We have undertaken an analysis of its biochemical function and expression pattern during murine development to gain insight into its role in leukemogenesis and normal function. Protein sequence data base analysis of the murine AF4 (mAF4) derived amino acid sequence does not strongly suggest its biochemical function however some provocative homologies are identi®ed. Two regions of sequence homology with the nuclear targeting motifs are present at amino acids 812 ± 816 and 885 ± 889 (La Casse and Lefebvre, 1995) . There is a JUN-like basic region of amino acids present at amino acid 809 ± 829. This basic region is not a clear-cut JUN/FOS homology because it does not conserve the internal uncharged amino acids which have been shown by mutagenesis to be important in sequence speci®c DNA binding (Neuber et al., 1989) . But it does maintain the spacing of the basic charges present in the JunB DNA binding domain and we hypothesize this region is involved in sequence speci®c nucleic acid binding. Amino acids 347 ± 560 of the derived mAF4 sequence show strong conservation with the reported transactivation domains of human AF4 and LAF-4 (Prasad et al., 1995; Ma and Staudt 1996) . The core of the region is serine-rich raising the possibility that phosphorylation may control this activity. We have extended the earlier analysis of transcriptional transactivation function of the human AF4 and LAF4 proteins to the murine AF4 protein and demonstrated the amino terminal region of AF4 (which is excluded from the der(11) fusion product) also has transactivation activity. This activity was not detected using a minimal reporter construct but was only noted when a GAL4 5 -HSVtk promoter was assayed. This suggests that interaction with CAAT-box and Sp1 site binding proteins are important to this activity. This region of AF4 had not been assayed for transactivation function in earlier reports however the homologous 5' region of LAF4 has been shown to have transcriptional transactivation function (Ma and Staudt, 1996) . In addition, transactivation by this region of AF4 was also identi®ed in yeast indicating the functional domain may be evolutionarily conserved although a yeast AF4 homolog has not yet been identi®ed. The nuclear localization of mAF4 studies using a GFP-mAF4 fusion construct further supports the theory that AF4 is a transcription factor. Down-regulation of Af4 with dierentiation is a repeating theme of Af4's developmental expression (Table 1) . This is the pattern in B-and T-lymphocytes, the heart, skeletal system, skin, and many epithelia. Af4 expression is present in the primitive hematopoietic system in many of the blood elements in the yolk sac and the cells in the para-aortic splanchnic mesoderm region. This raises the possibility that Af4 plays a role in both intra and extra-embryonic hematopoiesis (Zion, 1995) . The pattern of expression of the putative transcription factor Af4 suggests it plays a role in hematopoiesis and is reminiscent of the hematopoietic transcription factors AML1 (Okuda et al., 1996) , GATA2 (Tsai et al., 1994) , Ttg2/rbnt2 (Warren et al., 1994) and SCL/tal1 Kehrl, 1995) . Af4 expression is down-regulated in some mature B-and T-cells suggesting its down regulation may be required for lymphocyte maturation. Such a down-regulation would be analogous to the downregulation of the transcription factors c-myb (Shivdasani and Orkin, 1996) . and the homeobox genes HoxB3 and HoxA10 (Sauvageau et al., 1994) in general hematopoiesis. Af4's down-regulation in maturing Blymphocytes has not been noted in prior studies of human AF4 expression . However, these prior studies employed B-cell lines which were both neoplastic and had existed in vitro for a number of years. Therefore, the expression pattern seen in the mouse spleen may better re¯ect AF4 regulation in normal B-lymphocytes.
The expression of Af4 in endothelia is not surprising given the common embryonic origins of the vascular and hematopoietic systems and the isolation of a common endothelia-hematopoietic progenitor (Hauang and Terstappen, 1992) . The TAL-1 protein (Kappianpur et al., 1994) and CD34 surface antigen have been found to be co-expressed in murine endothelia and hematopoietic precursors (Young et al., 1995) . Cardiac Af4 is down-regulated at the same point in murine development at which the common atria and ventricles are generated (Theiler, 1989) . This is also when there is down-regulation of the myosin alpha-heavy chain (Lyons et al., 1990) and atrial down-regulation of myosin light chain-IV (Chien et al., 1993) .
In the skeletal system expression of Af4 develops at the stage of mesenchymal condensations which precede cartilagenogenesis. This stage of the development of the skeletal system is controlled by inductive signals from the Transforming Growth Factor-Betas, Bone Morphogenic Factors (BMP's), other peptide growth factors, and retinoids (Erlebacher et al., 1995) . If and how Af4 ®ts into these signal transduction pathways is unclear from these studies but could be an area of further research. Of these factors BMP-4 is particularly interesting because it appears essential for the mesodermal development which will lead to the blood and vascular systems (Winnier et al., 1995; Johansson and Wiles, 1995) . Transcription factors important in the development of the skeletal system include fos (Griogoriadis et al., 1995) and gli (Walterhouse et al., 1993) . Gli has a similar expression pattern of Af4 in the skeletal system and like Af4 is heavily expressed in the developing central nervous system.
The data presented here raises the possibility that the t(4;11) may disrupt normal AF4 function and that AF4 has an important role in the development of the hematopoietic, cardiovascular, and skeletal systems. The MLL translocations have already been postulated to a dominant negative eect on MLL protein function (Fidanza et al., 1996) . A disruption of two genes' normal function by a leukemia associated fusion transcript is not unprecedented having already been observed in the t(15;17) PML-RARa fusion (Warrell et al., 1993) . The der(11) gene product in the t(4;11) is thought to be the leukemogenic fusion protein (Bernard and Berger, 1995) and encodes a protein with a split AF4 transactivation region. This disruption of AF's transactivation region may eect AF4 function and contribute to leukemogenesis.
Materials and methods
cDNA cloning and sequencing
A random primed murine 70Z/3 (mouse pre-B lymphocyte) cDNA library cloned into lambda gt-11 was screened with the cross-hybridizing human AF4 cDNA pc664 for additional cDNA clone isolation a new born mouse kidney cDNA library cloned into the UNI-ZAP XR vector (STRATEGENE, LaJolla, CA) was screened (a generous gift of Dr Y Kanwar). Inserts were subcloned into the pT7Blue or pBluescript plasmids for DNA sequence analysis. DNA sequence analysis was done using the dideoxynucleotide chain-termination method (Sanger et al., 1977) with the Sequenase system (Amersham, Arlington Heights, IL). The DNA sequence of mAF4 has been deposited in Genbank with the accession number AF013131.
Interspeci®c mouse backcross mapping
Interspeci®c backcross progeny were generated by mating (C57BL/6J 6 M. spretus) F1 females and C57BL/6J males as described . A total of 205 N2 mice were used to map the AF4 locus. Fragments of 5.3, 3.3, 2.5, 2.1, 1.8, 1.5 and 1.2 kb were detected in BglI digested C57BL/6J DNA and fragments of 6.2, 5.3, 4.3, 3.4 , 2.1 and 1.5 kb were detected in BglII digested M. spretus DNA. In addition, EcoRI digestion produced fragments of 16.0, 3.8. 1.6 and 1.2 kb (C576BL/6J) and 15.0, 5.4, and 1.2 kb (M. spretus). The presence of absence of the M. spretus-speci®c fragments, which cosegregated, High levels throughout gestation a initial down-regulation by in situ hybridization was followed in backcross mice. The BglI and EcoRI data were combined. A description of the probes and RFLPs for the loci linked to AF4 has been reported previously (Benovic et al., 1991) . Recombination distances were calculated as described (Green, 1981) using the computer program SPRETUS MADNESS. Gene order was determined by minimizing the number of recombination events required to explain the allele distribution patterns.
Transcriptional activation studies
The pNB1 Af4 cDNA was used as a template to amplify products of approximately 1 kb with EcoRI restriction sites on both ends. These EcoRI products were designed to encode the portions of the murine Af4 shown in Figure 2a . An EcoRI fragment from the pNB1 open reading frame and the Af4 PCR products were cloned into pAS2-1 (Clontech, Palo Alto, CA). The SalI cloned was generated by ampli®cation of the sequences encoding murine AF4 amino acids 951 ± 1210 using PCR primers containing SalI restriction sites. This product was then cloned into pAS2-1. Restriction analysis of the construct and DNA sequencing revealed the constructs were in frame with GAL4 binding domain. The resulting plasmids were then transformed into yeast cells of the Y1945 reporter strain (Trp 7 ,Leu 7 ,His 7 , LacZ 7 ). Transformants were selected on yeast synthetic medium containing dextrose with all the essential amino acids except Trp 7 . Yeast colonies were assayed bgalactosidase activity according to the manufacturer's protocol (Clonetech, Palo Alto, CA) and the staining quantitated by visual observation by three observers (Vojteck et al., 1993) .
To assess transactivation in mammalian cells the Af4 EcoRI fragment and PCR products were also cloned into the eucaryotic expression vector pSG424 (Sadowski et al., 1989) , which encodes the DNA binding domain of yeast GAL4 (amino acids 1 ± 147), to give the clones EcoRI-1, EcoRI-2, and EcoRI-3. Restriction analysis of the construct and DNA sequencing revealed the constructs were in frame with GAL4 binding domain. The reporter plasmids used in luciferase assays was pGL2 (Baron et al., 1997) which contains ®ve copies of the DNA sequence bound by GAL4 followed by luciferase reporter. HeLa cells 1.5610 6 cells/ plate were transfected by lipofectamine methods (GIBCO/ BRL, Gaithersburgh, MD). Each transfection included 5 mg of pCE Lac, a galactosidase transfection control plasmid, 10 mg of eector plasmid and 10 mg of reporter plasmid. After 48 h of transfection, cell extracts were prepared and assayed for Luciferase activity (Promega, Madison, WI) and the b-galactosidase activity to normalize for variation in transfection eciency. For each eector construct luciferase activity was determined in triplicate in each experiment. Three separate experiments were done. Fold activation was calculated by comparison of the amount of luciferase activity produced (normalized for b-galactosidase activity) in extracts from cells transfected with Af4 containing plasmids relative to extracts from cells transfected with the parent pSG424 plasmid. Each clone was evaluated in three independent experiments. Western blot analysis was performed on the same cellular extract with proteinase inhibitor cocktail (Boehringer Mannheim, Indiapolis, IN) and 0.5 mM PMSF added. The cellular extracts were analysed by 10% polyacrylamide gel electrophoresis under denaturing conditions followed by Western transfer to PVDF membranes (Biorad, Hercules, CA). After blocking with powerded milk the ®lters were probed with an anti-GAL4 DNA binding domain monoclonal antibody (Clonetech, Palo Alto, CA).
For CAT assays HeLa cells (1. 5610 6 ) were transfected by lipofectine method (GIBCO BRL). Each transfection included 5 mg of internal reference pCE Lac, b-galactosidase plasmids, 10 mg of eector plasmid and 10 mg of receptor plasmid GAL4 5 tkCAT (Shi et al., 1991) . With ®ve copies of the DNA sequence bound by GAL4 upstream of the Herpes Simplex thymidine kinase promoter (base pairs 7105 to +51). Forty eight hours after transfection, cell lysates were prepared and analysed for b-galactosidase activity to normalize for variation in transfection eciency. CAT protein expression was determined by ELISA (Boehringer Mannheim; Indiapolis, IN), analysed in duplicate. Fold of activation by comparing the amount of CAT protein produced (normalized for b-galactosidase activity) in lysates from the various constructs to that of the lysate containing the parent pSG424 plasmid. The transactivation potential of each eector clone was evaluated in duplicate in three independent experiments (six independent transfections) Subcellular localization of mAF4 using GFP A¯uorescent fusion protein containing 1173 amino acids of mAF4 was constructed from the cDNA clone as follows. EcoRI digestion of the cDNA released 3521 base pairs of Af4 from the 5'terminal of the gene which was fused in frame at the carboxy-terminal of GFP-C2 vector (Clontech, Palo Alto, CA). The Green Fluorescent Protein (GFP) (Chal®e et al., 1994) from the jelly®sh Aequorrea victoria is used as a reporter for monitoring gene expression in vivo. The fusion vector contains a Kozak consensus sequence, the immediately early promoter of cytomegalovirus (CMV) to express fusions in mammalian cells. NIH3T3, HeLa, HL-60 and U2-OS cells were transfected using a commercial lipofection protocol (GIBCO, Gaithersburg, MD), in serum free medium and grown over night. Cells were then grown in the presence of 10% fetal calf serum for 24 and 48 h. The cells were then ®xed in 3.7% formalin in phosphate buered saline (PBS). Fixed cells were counter-stained with 1 mg/ml propidium idoide and mounted in 90% buered glycerol. The green uorescence was detected with a ZEISS¯uorescent microscope using 450 ± 490 nm excitation ®lter, 490 ± 585 nm readout ®lter and photographed.
Northern blot hybridization
Mouse poly-A selected RNA from heart, brain, spleen, lung, liver, skeletal muscle, kidney and testis was prepared and a Northern blot (CLONETECH, Palo Alto, CA) was hybridized sequentially with 32 P-labeled murine Af4 cDNA pz5b, the 303 base pair Af4 subclone used as a template for riboprobe generation, a human Af4 cDNA probe, the house keeping gene GAPDH and a cross-hybridizing human b-actin probe. The results were visualized by autoradiography with exposures ranging from 16 ± 60 h.
In situ hybridization
In situ hybridization (Sasaki and Hogan, 1993; Sitzman et al., 1995) was carried out according to the mafacturer's protocol using digoxigenin labelled uridine triphosphate as substrate by in vitro transcription (Boehringer Mannheim, Indianapolis.). A 303 base pair PCR product from mAF4 gene (3199 ± 3502) was used to generate riboprobes. The PCR product was cloned into the pGEM-T vector, downstream of T7 promoter and sequenced. Sense and anti-sense riboprobes were generated from linearized plasmids DNA using T7 RNA polymerase, by in vitro transcription. Various tissues and embryos at 7.5 ± 15.5 and 17.5 days post-coitum (p.c.) were collected from CD1 (Charles River, Wilmington, MA) mice. Both tissue and embryo's were ®xed in 4% paraformaldehyde overnight before embedding in paran. Paran embedded embryos were sagittaly sectioned (4 mm) and mounted on silanised slides. Hybridisation was carried out using sense and antisense digoxigenin-labeled ribo-probes at 608C in a humidi®ed chamber overnight. Unhybridized probes were washed o at 658C with 26, 16 and 0.56 SCC, 30 min each. Probes hybridized to the sections were detected by enzyme-linked immunoassay using an antibody conjugate (anti-digoxigenin alkaline phosphatase conjugate, anti-DIG-AP). Subsequent enzyme catalysed color reaction with 5-bromo-4-chloro-3-indolylphosphate (X-phosphate) and nitroblue tetrazolium salt (NBT) produces an insoluble blue precipitate which visualised hybrid molecules. Sections where counterstained with esoin.
